FDA Inspection 1326428 — Novo Nordisk A/S

Novo Nordisk A/S — FEI 3002807751

The FDA completed an inspection of Novo Nordisk A/S on Jun 10, 2025 in Kalundborg. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.